Delivery Order SPE2DB20D2104-SPE2DB23FU48Z
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,655.50 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a medical product, and has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of GEMTESA 75 MG TABLET 90S medical products. The contract, with a ceiling value of $2,252.86, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,410.13 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,310.68 for the supply of GEMTESA 75 MG TABLET 30S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,420.56 firm-fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is a Delivery Order valued at $16,819.82 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a prescription medication, with a performance period extending until July 9, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, with ID SPE2DB20D3505|SPE2DB24FT5Y9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,217.81 firm fixed-price delivery order is for the pharmaceutical product GEMTESA 75 MG TABLET 30S. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB22D3016|SPE2DB24FAGQ6) valued at $8,325.05 for the procurement of GEMTESA 75 MG TABLET 30S. The contract is a Firm Fixed Price arrangement with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 22, 2023. The award is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,049.21 delivery order contract is for the supply of GEMTESA 75 MG TABLET 90S, with a completion date of January 2, 2024. The contract is a Firm Fixed Price type, without any set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,528.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 10, 2024. The contract was awarded on May 9, 2024 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU48ZDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,427.96 for the supply of the pharmaceutical product GEMTESA 75 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD) that provides logistics, acquisitions, and technical services to the U.S. military. The contract has an ultimate completion date of July 21, 2023 and is a firm fixed-price delivery order, with no set-aside requirements. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DoD and Veterans Affairs (VA) healthcare facilities worldwide. This delivery order is likely a task order issued under that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/20/23 |